{"id":"NCT00464269","sponsor":"UCB Pharma","briefTitle":"Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures","officialTitle":"An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Brivaracetam in Subjects (>= 16 to 70 Years Old) With Partial Onset Seizures","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-09","primaryCompletion":"2008-12","completion":"2009-01","firstPosted":"2007-04-23","resultsPosted":"2016-04-13","lastUpdate":"2022-07-21"},"enrollment":400,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Epilepsy"],"interventions":[{"type":"OTHER","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Brivaracetam 2.5 mg","otherNames":[]},{"type":"DRUG","name":"Brivaracetam 10 mg","otherNames":[]},{"type":"DRUG","name":"Brivaracetam 25 mg","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Brivaracetam 5 mg/day","type":"EXPERIMENTAL"},{"label":"BRV 20mg/day","type":"EXPERIMENTAL"},{"label":"BRV 50mg/day","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the efficacy and safety of Brivaracetam to support the submission file in the indication of adjunctive treatment in adolescents and adults with partial onset seizures.","primaryOutcome":{"measure":"Partial Onset Seizure (Type I) Frequency Per Week Over the 12-week Treatment Period","timeFrame":"Baseline to 12-week Treatment Period","effectByArm":[{"arm":"Modified Intention-to-Treat (Placebo Treated Subjects)","deltaMin":2.15,"sd":null},{"arm":"Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects)","deltaMin":1.8,"sd":null},{"arm":"Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects)","deltaMin":1.96,"sd":null},{"arm":"Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects)","deltaMin":1.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG003","p":"=0.025"},{"comp":"OG000 vs OG002","p":"=0.492"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":2},"locations":{"siteCount":69,"countries":["United States","Australia","Brazil","Canada","Mexico"]},"refs":{"pmids":["24446953","27265725","27335114","27589414","28004320","27608437","28236727","27988967","28279891","29414542","29908435","32432339","34218211","35582748","35285519","34155568"],"seeAlso":["https://www.briviact.com/briviact-PI.pdf?v=1479491757","http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":98},"commonTop":["Somnolence","Dizziness","Headache","Fatigue","Nausea"]}}